Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
The bats soon begin to emerge, darting and swooping up and down the aisles, the amplified sounds of their bat chatter filling the historic building.
，更多细节参见heLLoword翻译官方下载
Жители Санкт-Петербурга устроили «крысогон»17:52
Sign up for our Future Earth newsletter to keep up with the latest climate and environment stories with the BBC's Justin Rowlatt. Outside the UK? Sign up to our international newsletter here.